Peptide Decoding
New?New to peptides?Start here →
Decoding

Dermorphin_Dosage, benefits & legal status

Also known as frog juice, Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser

Published August 24, 2026 · Updated October 4, 2026

A frog-skin opioid many times stronger than morphine, best known from horse racing scandals.

Nerve pain & healingOpioid peptideResearch onlyHigh-risk
Common vial size5 mg
DoseResearch only
FrequencyVaries
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNo established pattern

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Dermorphin?

Plain language first. The technical label stays, but it never stands alone.

Overview

An opioid from frog skin, much stronger than morphine, with no medical use and a history in horse doping. It sits in vendor catalogues next to recovery peptides and does not belong there.

The technical version

H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2, a heptapeptide isolated from Phyllomedusa frog skin. Highly selective mu-opioid receptor agonist with reported potency substantially exceeding morphine on a molar basis. The D-alanine at position 2 confers resistance to enzymatic degradation.

What it's used for

Studied as a research tool for opioid receptor biology. It has no approved medical use and is best known as a horse-doping agent.

02

How does Dermorphin work?

What it does in the body, and where.

This is an opioid, and everything that follows from that applies.

  1. 01
    It acts on the same receptor as morphine
    Dermorphin is a mu-opioid receptor agonist with high selectivity for that receptor over the others in the family.
  2. 02
    It is far more potent by weight
    Reported potency is many times that of morphine on a milligram basis, which is what makes dosing errors dangerous rather than merely wasteful.
  3. 03
    An unusual amino acid makes it durable
    The sequence contains a D-form amino acid, which is rare in natural peptides and slows enzymatic breakdown considerably.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Research tool for studying mu-opioid receptor biologyResearch only
  • Pain, as a research question onlyResearch only
  • Performance enhancement in racehorses, where it has been detected and prosecutednone

The published record

Research index

547

Papers and trials about Dermorphin

53 papers tagged human · 37 not reviews or lab · 0 clinical trial publications

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

In animals471
In the lab75
Reviews15
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 438 papers and 0 trials indexed in detail.

Dermorphin vial rendering
Compound field notes

At a glance

Four things to know about Dermorphin

01

Evidence

Research only

02

Category

Brain, mood and sleep

03

Common vial

5 mg

04

Half-life

Nothing published in humans

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, varies. No established pattern No range

No published human study establishes a schedule.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing published in humansNo figure

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

No draw available

Human research exposure was about 0.16 mg/kg IV in 1980s experiments. This is a potent opioid with no approved or established therapeutic dose, so we do not show a usable range.

07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Dermorphin keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 29% charged residues, 43% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Any non-laboratory use
  • Any concurrent opioid, sedative or alcohol use
  • Any respiratory condition
  • Pregnancy or breastfeeding
  • A history of substance use disorder

Stop and get help

These are emergencies. Seek care.
  • Slowed or shallow breathing, which is the way opioids kill
  • Extreme drowsiness or unresponsiveness
  • Any of the above in another person after exposure

Common effects

Expected, and usually mild.
  • Carries the full risk profile of a potent opioid, including respiratory depression, dependence and overdose.
  • Potency well above morphine means the margin for a dosing error is correspondingly smaller.

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Dermorphin approved?

And where the numbers on this page come from.

No. Dermorphin is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From published human studies. Not approved by a regulator for this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 438 records are indexed. Browse the records